Richard Burr: “This measure [S. 1160] was first introduced by then-Senator Barack Obama in the 110th Congress.”

If you can take the outline you just presented to me and get somebody from the Administration to fill in in between the action steps that are going to be taken, you might have a plan.

What does it mean for a small company when FDA misses these goals, and what does it mean to patients?

I oppose Ms. Kotagal's nomination and urge my colleagues to do the same.

Are you beginning to see the pattern as to why a plan is important? This has been a well-orchestrated event up to this point.